FOR COVID19 BRILLIANT VIOLET ANTI-HUMAN CD8A RPA-T8 AND BRILLIANT VIOLET ANTI-HUMAN CD154 ANTIBODY CLONE 24-31
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- 75N93020P00935
- Contractor
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- National Institutes of Health
- Award amount
- $14,024
- Period of performance
- Jul 22, 2020 – Aug 21, 2020
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- PSC 6505
- Place of performance
- CA
Public award description
FOR COVID19 BRILLIANT VIOLET ANTI-HUMAN CD8A RPA-T8 AND BRILLIANT VIOLET ANTI-HUMAN CD154 ANTIBODY CLONE 24-31
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.